Innate Pharma (IPHA) Pension (2017 - 2025)

Innate Pharma has reported Pension for 9 years, with the latest figure at $2.2 million in Q4 2025.

• For the quarter ending Q4 2025, Pension fell 23.27% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (down 23.27% YoY), and the FY2025 full-year result was $2.2 million, down 23.27% from the prior year.
• Pension for Q4 2025 stood at $2.2 million, down from $3.0 million in the prior quarter.
• The five-year high for Pension was $4.7 million in Q2 2021, with the low at $2.2 million in Q4 2025.
• Historically, Pension has averaged $3.0 million across 5 years, with a median of $2.8 million in 2022.
• Annual changes were most pronounced in 2021 — Pension plunged 99.89% — and 2025, when it gained 13.46%.
• Innate Pharma's Pension stood at $3.4 million in 2021, then dropped by 23.56% to $2.6 million in 2022, then grew by 0.95% to $2.6 million in 2023, then rose by 11.08% to $2.9 million in 2024, then declined by 23.27% to $2.2 million in 2025.
• The last three Pension figures came in at $2.2 million (Q4 2025), $3.0 million (Q2 2025), and $2.9 million (Q4 2024), per Business Quant data.